Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thienopyrimidine–Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer Cells
Nashrah Sharif Khan, Parvez Κhan, Mohammad Fawad Ansari, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 9, pp. 4173-4189
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition
Saleha Anwar, Anas Shamsi, Mohd Shahbaaz, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 142
Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry
Gayathri Rajendran, Deepu Bhanu, Baladhandapani Aruchamy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1250-1250
Open Access | Times Cited: 68
Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure‐activity relationship
Feng Gao, Gang Huang, Jiaqi Xiao
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 2049-2084
Closed Access | Times Cited: 104
Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy
Rashmi Dahiya, Taj Mohammad, Sonam Roy, et al.
International Journal of Biological Macromolecules (2019) Vol. 136, pp. 1076-1085
Closed Access | Times Cited: 95
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
Anas Shamsi, Saleha Anwar, Taj Mohammad, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 95
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy
Preeti Gupta, Taj Mohammad, Parvez Κhan, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109245-109245
Open Access | Times Cited: 88
Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis
Babita Aneja, Nashrah Sharif Khan, Parvez Κhan, et al.
European Journal of Medicinal Chemistry (2018) Vol. 163, pp. 840-852
Closed Access | Times Cited: 85
Expedition of sulfur‐containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade update
Kritika Laxmikeshav, Kumari Pooja, Nagula Shankaraiah
Medicinal Research Reviews (2021) Vol. 42, Iss. 1, pp. 513-575
Closed Access | Times Cited: 71
Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination
Wei Zhao, Xiao‐Di Zheng, Paula Yun‐Zhi Tang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1778-1808
Closed Access | Times Cited: 34
Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4
Parvez Κhan, Aarfa Queen, Taj Mohammad, et al.
Journal of Natural Products (2019) Vol. 82, Iss. 8, pp. 2252-2261
Closed Access | Times Cited: 73
Binding mechanism of caffeic acid and simvastatin to the integrin linked kinase for therapeutic implications: a comparative docking and MD simulation studies
Mehak Gulzar, Shahid Ali, Faez Iqbal Khan, et al.
Journal of Biomolecular Structure and Dynamics (2018) Vol. 37, Iss. 16, pp. 4327-4337
Closed Access | Times Cited: 60
Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy
Deeba Shamim Jairajpuri, Taj Mohammad, Kirtika Adhikari, et al.
ACS Omega (2020) Vol. 5, Iss. 24, pp. 14720-14729
Open Access | Times Cited: 49
Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities
Yunhe Liu, Ziyue Wang, Yifei Du, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118109-118109
Closed Access
A review on pyrimidine-based pharmacophore as a template for the development of hybrid drugs with anticancer potential
Shivam Sharma, M. Arockia Babu, Roshan Kumar, et al.
Molecular Diversity (2025)
Closed Access
Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones
Maria Voura, Parvez Κhan, Savvas Thysiadis, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Synthesis and evaluation of novel α-substituted chalcones with potent anti-cancer activities and ability to overcome multidrug resistance
Sharon Riaz, Maheen Iqbal, Rahim Ullah, et al.
Bioorganic Chemistry (2019) Vol. 87, pp. 123-135
Closed Access | Times Cited: 43
Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy
Farheen Shamsi, Phool Hasan, Aarfa Queen, et al.
Bioorganic Chemistry (2020) Vol. 98, pp. 103754-103754
Closed Access | Times Cited: 39
Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX
Babita Aneja, Aarfa Queen, Parvez Κhan, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 9, pp. 115424-115424
Closed Access | Times Cited: 33
Design, synthesis and evaluation of calix[4]arene-based carbonyl amide derivatives with antitumor activities
Lin An, Chan Wang, Youguang Zheng, et al.
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 112984-112984
Closed Access | Times Cited: 32
Exploring the promising potential of noscapine for cancer and neurodegenerative disease therapy through inhibition of integrin-linked kinase-1
Mohammed Ageeli Hakami, Bader S. Alotaibi, Samia S. Alkhalil, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 130146-130146
Closed Access | Times Cited: 3
Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach
Katja Silbermann, Sven Marcel Stefan, Randa Elshawadfy, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 9, pp. 4383-4400
Closed Access | Times Cited: 30
Design, synthesis, and anti-proliferative evaluation of 1H-1,2,3-triazole grafted tetrahydro-β-carboline-chalcone/ferrocenylchalcone conjugates in estrogen responsive and triple negative breast cancer cells
Bharvi Sharma, Liang Gu, Ruvesh Pascal Pillay, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 26, pp. 11137-11147
Closed Access | Times Cited: 23
Aurora B kinase: a potential drug target for cancer therapy
Azaj Ahmed, Anas Shamsi, Taj Mohammad, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 8, pp. 2187-2198
Closed Access | Times Cited: 22
Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy
Mudasir Nabi Peerzada, Parvez Κhan, Nashrah Sharif Khan, et al.
ACS Omega (2020) Vol. 5, Iss. 36, pp. 22759-22771
Open Access | Times Cited: 19
Chalcones As Broad‐Spectrum Antimicrobial Agents: A Comprehensive Review And Analysis Of Their Antimicrobial Activities
Tariq Nawaz, Affifa Tajammal, Aisha Waheed Qurashi
ChemistrySelect (2023) Vol. 8, Iss. 45
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top